美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Akcea Therapeutics Inc.

18.17

0.0000

成交量：- -

成交額：- -

市值：18.49億

市盈率：-32.26

高：18.17

開：18.17

低：18.17

收：18.17

52周最高：21.71

52周最低：8.00

股本：1.02億

流通股本：1,793.29萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.5632

每股收益(LYR):0.2936

淨資產收益率：-9.80%

總資產收益率：-5.95%

市淨率：3.86

市盈率(LYR):61.89

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Akcea Therapeutics Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.akceatx.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Akcea治療公司最初於2014年12月成立於特拉華州，為Ionis Pharmaceuticals, Inc.的全資子公司，並於2015年創立了自己的業務。該公司是一家後期生物製藥公司，專註於開發和商業化藥物以治療由脂質障礙引起的嚴重心臟代謝疾病的患者。該公司的目標是成為首屈一指的為治療不足的脂質疾病提供治療的公司。該公司正在推進四種具有治療多種疾病潛力的新型藥物的成熟渠道。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AKCA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AKCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKCA\",,,,,undefined,":{"symbol":"AKCA","market":"US","secType":"STK","nameCN":"Akcea Therapeutics Inc.","latestPrice":18.17,"timestamp":1602273600000,"preClose":18.17,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":17932931,"shares":101759772,"eps":-0.563165,"marketStatus":"停牌","change":0,"latestTime":"10-09 16:00:00 EDT","open":18.17,"high":18.17,"low":18.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.563165,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1500004800000,"exchange":"NASDAQ","adjPreClose":18.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKCA\",,,,,undefined,":{"symbol":"AKCA","floatShares":17932931,"roa":"-5.95%","roe":"-9.80%","lyrEps":0.2936,"shares":101759772,"dividePrice":0,"high":18.17,"amplitude":0,"preClose":18.17,"low":18.17,"week52Low":8,"pbRate":"3.86","week52High":21.705,"institutionHeld":0,"latestPrice":18.17,"eps":-0.563165,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.563165,"open":18.17,"prevYearClose":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKCA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-14","symbol":"AKCA","reason":null,"defaultRemindTime":1602682200000,"announcedDate":"2020-10-06","type":"delisting","dateTimestamp":1602648000000},{"market":"US","date":"2020-10-13","symbol":"AKCA","reason":null,"defaultRemindTime":1602595800000,"announcedDate":"2020-10-06","type":"delisting","dateTimestamp":1602561600000},{"market":"US","date":"2020-08-04","symbol":"AKCA","fiscalQuarterEnding":"2020/06","expectedEps":-0.3,"name":null,"time":"盤後","type":"earning","dateTimestamp":1596513600000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2020-05-05","symbol":"AKCA","fiscalQuarterEnding":"2020/03","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1588651200000,"reportTimeType":"post","actualEps":-0.42},{"date":"2020-02-25","symbol":"AKCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":2.1,"defaultRemindTime":1582664400000,"name":null,"time":"盤後","dateTimestamp":1582606800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKCA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKCA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKCA","date":"2020-10-12","current":-32.264079,"percent":0.118727,"low":-58.203477,"twenty":-28.017058,"median":-19.02921,"eighty":-15.189182,"high":44.622078,"avg":-18.595705,"sd":17.057228,"marketCap":1848975057},"quantilePoints":[],"updateTime":1774750937106},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.akceatx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Akcea治療公司最初於2014年12月成立於特拉華州，為Ionis Pharmaceuticals, Inc.的全資子公司，並於2015年創立了自己的業務。該公司是一家後期生物製藥公司，專註於開發和商業化藥物以治療由脂質障礙引起的嚴重心臟代謝疾病的患者。該公司的目標是成為首屈一指的為治療不足的脂質疾病提供治療的公司。該公司正在推進四種具有治療多種疾病潛力的新型藥物的成熟渠道。","exchange":"NASDAQ","name":"Akcea Therapeutics Inc.","nameEN":"Akcea Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AKCA\",market:\"US\",,,undefined,":null}}